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Abstract Angiogenesis requires the temporal coordination of the proliferation and the
migration of endothelial cells. Here, we investigated the regulatory role of microRNAs (miRNAs) in
harmonizing angiogenesis processes in a three-dimensional in vitro model. We described a
microRNA network which contributes to the observed down- and upregulation of proliferative and
migratory genes, respectively. Global analysis of miRNA–target gene interactions identified two
sub-network modules, the first organized in upregulated miRNAs connected with downregulated
target genes and the second with opposite features. miR-424–5p and miR-29a-3p were selected for
the network validation. Gain- and loss-of-function approaches targeting these microRNAs impaired
angiogenesis, suggesting that these modules are instrumental to the temporal coordination of
endothelial migration and proliferation. Interestingly, miR-29a-3p and its targets belong to a
selective biomarker that is able to identify colorectal cancer patients who are responding to anti-
angiogenic treatments. Our results provide a view of higher-order interactions in angiogenesis that
has potential to provide diagnostic and therapeutic insights.
Introduction
The expansion of a vascular network through the sprouting angiogenesis (SA) process requires a
coordinated control of many cellular functions, including the activation of quiescent endothelial cells
(ECs), cell protrusion, basal lamina and extracellular matrix degradation, cell migration and prolifera-
tion, deposition of new basement membrane, cell junctions and cell polarity alteration
(Carmeliet and Jain, 2011). In response to an angiogenic stimulus, activated ECs acquire distinct
specialized phenotypes to accomplish these different tasks (Jakobsson et al., 2010), ultimately lead-
ing to the formation of a new functional vascular network. In particular, during SA, ECs dynamically
switch from a tip phenotype, which guides the network expansion, to a stalk cell state that is charac-
terized by active proliferation.
Vascular Endothelial Growth Factor-A (VEGF-A) is the most prominent cytokine that activates a
genetic program that sustains this morphogenetic process (Simons et al., 2016). Transcriptomic
analysis of tip and stalk cells isolated from the retinal vascular plexus showed differential expression
of molecular determinants, represented by genes that are involved in extracellular matrix remodeling
for tip cells and that encode components of the Notch signaling pathway for stalk cells (del Toro
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et al., 2010; Strasser et al., 2010). It also has been proposed that the EC fate decision towards the
tip or stalk cell phenotype is affected by VEGF-A gradient concentration in the surrounding extracel-
lular matrix and by VEGF receptors expression levels (Gerhardt et al., 2003). Nevertheless, the
gene expression regulatory events that sustain the initial transition from quiescent to activated ECs
in response to an angiogenic stimulus have not yet been fully elucidated. We hypothesized that such
phenotypic transition would require profound transcriptomic alterations that are brought about
through the coordination of multiple regulation layers, including microRNA-mediated post-transcrip-
tional regulation.
MicroRNAs (miRNAs) are a class of small non-coding RNAs that extensively modulate gene
expression at the post-transcriptional level by targeting the mRNAs of protein-coding
genes, directing their repression through mRNA degradation or (to a lesser extent) inhibition of pro-
tein translation (Guo et al., 2010). Interestingly, one of the first functions attributed to miRNAs was
the control of developmental processes in which a morphogen gradient directs cell fate by activating
specific genetic programs (Inui et al., 2012; Ivey and Srivastava, 2015). In this scenario, miRNAs
are an integral part of the regulatory network that allows transitions between different cell states
(Hornstein and Shomron, 2006). A role for miRNAs in ECs biology and vascular development has
been established in vitro and in vivo by inhibition of two endonucleases that are required for mature
miRNAs generation, namely Dicer and Drosha (Ha and Kim, 2014). The consequent reduction in the
level of miRNAs resulted in alteration of several key properties of ECs, including their sprouting abil-
ity (Kuehbacher et al., 2007), and impaired postnatal angiogenesis (Sua´rez et al., 2008).
The activity of specific miRNAs in connection with the VEGF signaling pathway components has
been studied more extensively (Dang et al., 2013). Several studies have demonstrated that miR-15a
and miR-16, among other miRNAs, repress VEGF expression (Chamorro-Jorganes et al., 2011;
Yin et al., 2012), whereas miR-126 promotes VEGF signaling by targeting the downstream effector
PIK3R2 (Fish et al., 2008). Furthermore, miR-27b and miR-221 are required for tip cell specification
(Biyashev et al., 2012; Nicoli et al., 2012). Recently, RNA-sequencing (RNAseq) technology allowed
the generation of a complete annotation of the miRNAs that are expressed by two-dimensional cul-
tured human ECs in normal (Kuosmanen et al., 2017) or hypoxic (Voellenkle et al., 2012) condi-
tions. Yet, the extent to which miRNAs could affect ECs phenotypic specification during SA has not
been fully captured to date. Using RNAseq technology and network analysis, we exploited a three-
dimensional model of SA that specifically describes the lateral inhibition-driven tip cell selection
(Heiss et al., 2015; Nowak-Sliwinska et al., 2018), which is considered to be the first step in capil-
lary nascence (Eilken and Adams, 2010). The information obtained was used to generate a co-
expression network encompassing the post-transcriptionally regulated interactions between modu-
lated miRNAs and their predicted protein-coding gene targets. Here, we show that in the initial step
of SA, miRNAs act cooperatively to give robustness to the specification of the tip cell phenotype by
reducing the expression of genes that are associated with cell-cycle progression and of members of
the mitogen-associated protein kinase (MAPK) cascade that sustains VEGF-A-mediated cell prolifera-
tion, while de-repressing genes that are involved in cell migration and extracellular matrix
remodeling.
Results
VEGF-A induces the tip phenotype of endothelial cells in a 3D model of
sprouting angiogenesis
To study the activation of quiescent endothelial cells induced by an angiogenic stimulus, and the
impact that miRNAs may exert on this process, we exploited a three-dimensional (3D) model that
mimics the initial phase of SA in vitro (Heiss et al., 2015; Nowak-Sliwinska et al., 2018). ECs were
induced to form 3D spheroids that are characterized by mature EC–EC junctions that are responsible
for quiescent proliferation state (Weidemann et al., 2013). Spheroids were then embedded in a 3D
collagen matrix and exposed to VEGF-A to trigger SA and to stimulate the formation of capillary-
like structures (Figure 1A). Spheroids that had been exposed to VEGF-A for 18 hr (SPHV) and con-
trol spheroids (SPHC) were then processed for long- and small-RNAseq. Expression analysis of pro-
tein-coding genes identified 3071 differentially expressed (DE) genes in SPHV compared to SPHC
(Figure 1—figure supplement 1A), revealing dramatic changes in the global transcriptomic profile
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during the early phase of sprouting. Upregulation of VEGFR2, the major VEGF signal transducer,
was validated by real-time PCR and Western blot analysis (Figure 1—figure supplement 1B–D). By
looking at the expression of known tip and stalk cell markers (De Bock et al., 2013; del Toro et al.,
2010; Strasser et al., 2010), we observed a general upregulation of tip marker genes and a downre-
gulation of stalk marker genes in the comparison between SPHV and SPHC (Figure 1B). To visualize
the organization of tip and stalk cells in this model, we analyzed the tip cell markers DLL4 and
CXCR4 by immunofluorescence, or we transduced ECs with a fluorescent reporter of Notch activity
to visualize stalk cells (Figure 1—figure supplement 2A). Although the EC sprouts strongly
expressed DLL4 and CXCR4, cells in which the Notch reporter was activated were present only occa-
sionally, so ECs largely acquired a tip-cell phenotype. Furthermore, manipulation of the Notch path-
way by the g-secretase inhibitor DAPT or by exogenous DLL4 resulted in increased or reduced
sprouting, respectively (Figure 1—figure supplement 2B). Altogether, these observations indicate
that this sprouting model can be used, at this specific developmental time point, to represent the
early phase of VEGF-A response that involves activation of quiescent ECs and differentiation to tip
cells.
To identify key biological pathways or that set of genes that is relevant to the sprouting process,
the gene expression dataset was interrogated by taking advantage of Gene Set Enrichment Analysis
(GSEA) (Subramanian et al., 2005). When comparing SPHV with SPHC, this analysis confirmed the
upregulation of known VEGF-A responder genes (‘VEGF-A UP’), and revealed a positive enrichment
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Figure 1. VEGF-A induces the tip phenotype of endothelial cells in a 3D model of sprouting angiogenesis. (A) EC spheroids were embedded in a
collagen matrix and stimulated with VEGF-A to induce endothelial cell sprouting. RNA-sequencing analysis was performed on control spheroids (SPHC)
not stimulated with VEGF-A, and on spheroids after 18 hr from stimulus (SPHV). Scale bars, 200 mm. (B) Heatmaps showing the expression of tip and
stalk cell markers in SPHC and SPHV. Color bars indicate log2(fold change) (log2FC) in the comparison SPCV versus SPHC. (C) Positively enriched gene
sets identified by the GSEA study in the genesets collection for canonical pathways. False discovery rate (FDR) was accepted when q value <0.05.
The online version of this article includes the following figure supplement(s) for figure 1:
Figure supplement 1. Expression profile of protein-coding genes annotated from the RNA-sequencing data.
Figure supplement 2. Organization of tip and stalk cells and the effect of Notch pathway manipulation in EC spheroids.
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of gene sets that are representative of several biological pathways and classes of
molecules, including ‘Translation’, ‘Cell adhesion molecules’, ‘Integrin pathway’, ‘Extracellular matrix
organization’, and ‘Collagen formation’. Altogether, these alterations in gene expression mirror the
transcriptional landscape that allows the migratory process. Other representative enriched pathways
included ‘Oxidative phosphorylation’ and ‘Lysosome’ (Figure 1C).
Early VEGF-A response does not involve cell proliferation
Activation of the VEGF pathway through VEGF receptors initiates a signaling cascade that promotes
the proliferation of ECs, among other actions (Simons et al., 2016). Nonetheless, and in agreement
with the non-proliferating tip cell phenotype, GSEA showed a strongly negative
enrichment score (ES) for cell-cycle-controlling genes (Figure 2A). Indeed, when looking at the
expression levels of genes belonging to the ‘cell cycle’ KEGG pathway (Kanehisa et al.,
2016), expression analysis showed that 52 genes out of 113 were DE in SPHV compared to SPHC, of
which 50 were downregulated (Figure 2B). Hypergeometric test confirmed a statistically significant
over-representation of this subset of genes among all the DE genes (P = 7.40x10-5). Only cyclin D2
(CCND2) and cyclin E1 (CCNE1), two genes belonging to the cyclin family and participating in the
G1phase of the cell cycle, were upregulated. The finding that VEGF-A did not activate the prolifera-
tion of ECs and the accompanying DNA synthesis was also confirmed by the negative ES of gene
sets that are representative of pyrimidine metabolism (Figure 2C) and, to a lesser extent, purine
metabolism (Figure 2D). Indeed, we observed a general downregulation of genes involved in de
novo synthesis of nucleotides (Figure 2—figure supplement 1A). Downregulations of the cyclin B1
gene and of IMPDH2, the rate-limiting enzyme in de novo guanine nucleotide biosynthesis, were val-
idated by a real-time PCR assay (Figure 2—figure supplement 1B,C). We then measured the activi-
ties of the enzymes PPAT and CAD, which are considered to be indices of de novo synthesis of
purine and pyrimidine nucleotides and of ATIC, which catalyzes the last step of purine
synthesis, respectively. VEGF-A stimulation decreased the activity of these three enzymes in the 3D
model (Figure 2E) indicating that, in this condition, de novo nucleotide synthesis is not required. On
the contrary, their activity significantly increased in a control experiment performed with ECs cul-
tured in 2D conditions (Figure 2—figure supplement 1D). Measurement of the percentage of cells
that entered the S phase of the cell cycle confirmed that SPHC displayed a quiescent, non-prolifer-
ative status, and that VEGF-A was not able to trigger cell proliferation in
spheroids significantly within an 18-hr time frame (Figure 2F). By contrast, VEGF-A activity on cell
proliferation was well evident in cells cultured in standard 2D conditions, both in a proliferation assay
and in a GSEA of the corresponding microarray data (Figure 2—figure supplement 1E,F). Further-
more, ECs that were mitotically inactivated by mitomycin C treatment maintained the ability to
migrate and to form endothelial sprouts (Figure 2G). Taken together, these observations indicate
that, in 3D conditions, early VEGF-A activity is primarily directed towards cell migration rather than
towards cell proliferation.
A miRNA-dependent regulatory network sustains acquisition of the tip
cell phenotype
Analysis of the small-RNAs sequencing data allowed the annotation of 639 mature miRNAs
that were expressed by ECs across the two experimental conditions (SPHC and SPHV), at levels
above a fixed cutoff (raw counts = 5) (Figure 3—source data 1). To assess the impact of endoge-
nous miRNAs on the phenotypic differentiation that occurs during SA, we applied a bioinformatics
pipeline based on the co-expression analysis of miRNAs and protein-coding genes, the prediction of
miRNA target genes, and the association of miRNAs with biological pathways, followed by network
analysis (Figure 3A). We first performed pair-wise correlation analysis between miRNAs and the
expression of protein-coding expression, and plotted the distribution of the correlator (Figure 3B).
We then isolated the subset of pairs that contained evolutionarily conserved or non-conserved
miRNA–target gene interactions, based on TargetScan predictions (Agarwal et al., 2015). The fre-
quency distribution of the correlator for the conserved interactions subset showed a significant
enrichment in negative correlations compared to that for the entire dataset (Figure 3B, blue line).
This is indicative of the repressive activity exerted by miRNAs on their targets; that is, when a miRNA
is upregulated, its protein-coding gene target is downregulated and vice-versa. By contrast, the
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Figure 2. Early VEGF-A response does not involve cell proliferation. (A) GSEA plot showing negative association
with the ‘cell cycle’ gene set in SPHV compared to SPHC. (B) Heatmap representing the expression of genes that
are included in the KEGG pathway ‘cell cycle’ and are differentially expressed with a log2(Fold Change)>0.5,
FDR < 0.05 when comparing SPHV versus SPHC. Color bar indicates log2(fold change). (C, D) GSEA plots showing,
Figure 2 continued on next page
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non-conserved interactions subset did not show any significant alteration in the correlator frequency
distribution (Figure 3—figure supplement 1A). Considering that target-site conservation is believed
to be an indication of functional repression for mammalian miRNAs (Friedman et al., 2009), the inte-
gration of the SA gene expression dataset with information about evolutionarily conserved miRNA–
target gene interactions provides information on the global activity of miRNAs taking place during
the early sprouting phase. Therefore, this strategy permits the identification of target genes and bio-
logical processes that are more likely to be affected by miRNA-mediated post-transcriptional
regulation.
GSEA-based analysis of correlation between miRNA expression and groups of genes participating
in the regulation of specific biological pathways, represented as gene sets, was also used to support
our findings (Figure 3C). This analysis identified five clusters of genesets representing distinct bio-
logical functions that are modulated during SA, together with their associated miRNAs. Gene ontol-
ogy-based enrichment analysis performed on the genes contained in each cluster showed the
following classes: 1) extracellular matrix remodeling and cell migration, 2) protein translation and
metabolic processes, 3) intracellular signaling pathways, 4) RNA and protein processing, and, 5) cell
cycle, DNA repair and MAPK cascade (Figure 3D). Clusters 1 and 2 contained genes that are mostly
upregulated in SPHV compared to SPHC, whereas clusters 3, 4 and 5 contained genes that are
mostly downregulated. To generate the global post-transcriptional regulatory network that sustains
SA, the results from the above analyses were integrated. The resulting miRNA-centered co-expres-
sion network is composed of 149 miRNAs and 717 protein-coding genes connected by 1713 edges
(Figure 4 and Figure 4—source data 1). This network is essentially characterized by two individual
components: one representing upregulated miRNAs connected with downregulated target genes,
and one representing downregulated miRNAs connected with upregulated target genes. Degree
distribution for both miRNAs (out-degree) and protein-coding genes (in-degree) observed a power-
law behavior (Figure 3—figure supplement 1B,C), indicating that this network is compatible with
the scale-free hypothesis, a typical feature of biological networks (Barabasi and Posfai, 2016).
The ERK gene module is under the control of a miRNA network in
sprouting angiogenesis
VEGF-mediated EC proliferation and migration recognize the ERK pathway (Wong and Jin, 2005)
and p38 MAP kinase activity (Rousseau et al., 2000), respectively, as master signaling modules
(Simons et al., 2016). The data shown so far demonstrate that genes controlling cell proliferation
were strongly downregulated (Figure 2), as were the expression levels of miRNAs correlated with
genes associated with cell division and the MAPK cascade (Figure 3D). On these bases, we asked
whether miRNAs have a role in suppressing the proliferative signal downstream VEGF-A through
ERK pathway inhibition, while supporting cell migration in a 3D context. To this purpose, we interro-
gated the previously defined global post-transcriptional network (Figure 4—source data 1), and
extracted the nodes corresponding to genes that encode known MAP kinases (Craig et al., 2008)
together with their targeting miRNAs. Mapping of these interactions generated a network com-
posed of one major component, which represents the inhibitory activity of miRNAs over several
Figure 2 continued
respectively, negative association with ‘pyrimidine metabolism’ and ‘purine metabolism’ gene sets in SPHV
compared to SPHC. FDR was accepted when q value < 0.05. (E) Measure of the VEGF-A-induced enzymatic
activity of three enzymes involved in de novo nucleotide synthesis in SPHC and SPHV. PPAT, phosphoribosyl
pyrophosphate amidotransferase; ATIC, 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP
cyclohydrolase; CAD, carbamoyl-phosphate synthetase 2/aspartate transcarbamylase/dihydroorotase. Data are
represented as mean ± SEM of n = 3 experiments. (F) Cell proliferation rate analysis in SPHC and SPHV performed
by evaluation of EdU incorporation into the newly synthetized DNA. Representative plots of n = 3 experiments.
Data represent the mean percentage of proliferating cells ± SEM of n = 3 experiments. p<0.05 in the comparison
between SPHC and SPHV. (G) Sprouting assay performed with ECs pre-treated with the cell replication blocker
mitomycin C, and the corresponding quantification of sprout area. Data are represented as mean ± SEM from
n = 3 experiments. ***, p<0.001; **, p<0.01; *, p<0.05; ns, not significant.
The online version of this article includes the following figure supplement(s) for figure 2:
Figure supplement 1. Expression profile of genes involved in nucleotide synthesis and cell proliferation assays.
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MAP kinases (Figure 5A). These MAP kinases showed reduced expression in SPHV compared to
SPHC. The TAOK1 gene, whose protein product is a kinase that activates stress response
(Raman et al., 2007), and MAPK1, whose protein product is ERK2, were the most targeted genes in
this sub-network, being targeted by 11 and 7 different miRNAs, respectively. Notably, all
components constituting the ERK module, namely C-Raf (RAF1), MEK (MAP2K1) and ERK2 (MAPK1),
were represented. Among the four members composing the p38MAPK family (p38a, -b, -g and -d),
only p38a (MAPK14) was present, but this gene was not connected with the major component of
the network because its expression is increased in SPHV compared to SPHC. Downregulation of
RAF1, MAP2K1, MAPK1 and TAOK1, and upregulation of MAPK14 in SPHV compared to SPHC, was
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Figure 3. Construction of the post-transcriptional regulatory network that sustains acquisition of the tip cell phenotype. (A) Schematic view of the
computational approach used to generate the post-transcriptional regulatory network. (B) Distribution of the correlator (Pearson coefficient) of the pair-
wise analysis that considered the expression profile of all miRNAs and of protein-coding genes expressed in SPCH and SPHV. The gray dashed curve
represents the null hypothesis distribution (uncorrelated miRNA–protein coding gene pairs) obtained by sample randomization with 1000 permutations;
the red curve represents all pair-wise miRNA–protein-coding gene interactions; the blue curve represents the subset of miRNA–protein-coding gene
pairs containing an evolutionarily conserved interaction as predicted by the TargetScan database. The blue arrow points to the enrichment in negative
correlations. The red dashed line indicates the statistical significance threshold chosen for the correlator (P < 0.05). (C) Association matrix of
the expression profiles of miRNAs (columns) with functional gene sets (rows) representing canonical pathways. Significant associations (FDR < 0.05) are
shown in red (positive) or blue (negative). White, not significant. Biologically relevant clusters are highlighted with different colors. (D) For each cluster in
(C), genes contributing to enrichment in the correlated gene sets were analyzed by functional annotation. Graph shows –Log(P value) of representative
gene ontology terms.
The online version of this article includes the following source data and figure supplement(s) for figure 3:
Source data 1. miRNAs annotation.
Figure supplement 1. Non-conserved miRNA-target gene interactions analysis and network degree analysis.
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validated by real-time PCR (Figure 5B). Furthermore, ERK activity was measured in SPHC and SPHV
by Meso Scale Technology (MSD) and expressed as P-ERK/total ERK ratio in order to take variations
in total ERK expression into account. Figure 5C shows that ERK activity decreases after VEGF treat-
ment. We also analyzed the effect in the sprouting model of SHC 772984 or SB 202190 compounds,
which inhibit ERK1/2 and p38MAPK, respectively. Effective inhibitor concentrations were assessed
by evaluating the inhibitory activity on VEGF-A-induced enzyme phosphorylation (Figure 5—figure
supplement 1). As shown in Figure 5D, treatment with the ERK inhibitor SCH 772984 did not have
any effect on sprouting, confirming that ERK activity is not required, and in agreement with the
observed low proliferation rate (Figure 2). By contrast, treatment with p38MAPK inhibitor SB
202190 completely abrogated the ability of ECs to migrate and to form sprouts.
DICER knock-down rescues the proliferative effect of VEGF-A
To demonstrate a regulatory role exerted by miRNAs on their predicted target genes and,
more generally, to confirm the involvement of miRNAs in the control of the sprouting process, we
removed mature miRNAs from the system by inactivating DICER, one of the endonucleases responsi-
ble for the generation of mature miRNAs from their precursors (Ha and Kim, 2014). This approach,
which investigated the effects of miRNAs on the global post-transcriptional network, was preferred
over the inhibition of individual miRNAs. Cells in which DICER expression was knocked-down by a
short-hairpin RNA (DICERKD) showed a reduction of sprouting to about 50% of that seen in cells
Figure 4
microRNAs
Cell Cycle
RNA processing
Intracellular signaling
Metabolism
ECM remodeling
Figure 4. Graphical representation of the post-transcriptional network. The network consists of two major, independent components. The component
on the left includes the interactions between upregulated miRNAs and their respective downregulated target genes; the component on the right
includes the interactions between downregulated miRNAs and their respective upregulated target genes. Yellow diamonds represent miRNAs, circles
represent their target genes, colored on the basis of the gene ontology cluster to which they belong. Edges are the miRNA–target gene pairs with a
predicted direct interaction and a significant negative correlation.
The online version of this article includes the following source data for figure 4:
Source data 1. Co-expression network edges.
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transduced by non-targeting shRNA (DICERWT) (Figure 6—figure supplement 1A), in agreement
with previous observations (Kuehbacher et al., 2007). Effective DICER knock-down was verified by
real-time PCR (Figure 6—figure supplement 1B). Then, we measured RAF1, MAP2K1, MAPK1,
TAOK1, and MAPK14 expression in SPHV generated with DICERWT or DICERKD cells by real-time
PCR. All of these genes were upregulated in the DICERKD condition (Figure 6A), indicating that their
expression is subjected to a miRNA-mediated post-transcriptional control. The amount of P-ERK
also increased in DICERKD spheroids (Figure 6B). We repeated the sprouting assay with DICERKD
spheroids in the presence of the ERK inhibitor SCH 772984. DICERWT spheroids were not affected
by ERK inhibition, as shown previously in Figure 5D. Nonetheless, DICERKD spheroids
that were treated with the ERK inhibitor showed a further reduction of sprouting (Figure 6C,D), con-
firming that removal of miRNAs by DICER knock-down restored ERK pathway activity and thus sensi-
tizing cells to the ERK inhibitor SCH 772984.
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Figure 5. ERK activation is not required for sprouting and the ERK module is repressed by miRNAs. (A) Sub-
network representing miRNAs targeting MAPK genes, derived from the global post-transcriptional network. The
ERK module, consisting of RAF1 (C-Raf), MAP2K1 (MEK) and MAPK1 (ERK2), is highlighted by red circles. MAPK14
(p38a) is highlighted by a blue circle. (B) Real-time PCR validations of the RNA-sequencing data for some of the
MAPK sub-network members, in SPHC and SPHV. Data are represented as mean ± SEM for n = 3 experiments. (C)
ERK activity in SPHC and SPHV measured by Meso Scale Discovery (MSD) technology and expressed as the ratio
of P-ERK/total ERK. Data are represented as mean ± SEM from n = 4 experiments. (D) Sprouting assay performed
in the presence of the ERK inhibitor SHC 772984 or in the presence of the p38 inhibitor SB 202190, and the
corresponding quantification of sprout area. Scale bars, 200 mm. ****, p<0.0001; ***, p<0.001; **, p<0.01; *,
p<0.05; ns, not significant.
The online version of this article includes the following figure supplement(s) for figure 5:
Figure supplement 1. Assessment of the effective concentrations of ERK and p38 inhibitors in ECs.
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Figure 6. DICER knock-down rescues VEGF-A proliferative effect. (A) Real-time PCR analysis of RAF1, MAP2K1,
MAPK1, TAOK1, and MAPK14 in SPHV generated with DICERWT cells or DICERKD cells. Data are represented as
mean ± SEM from n = 3 experiments. (B) ERK activity in SPHV generated with DICERWT cells or DICERKD cells
measured by MSD and expressed as the ratio of P-ERK/total ERK. Data are represented as mean ± SEM from
n = 3 experiments. (C) Sprouting assay performed with spheroids generated with DICERWT cells or DICERKD cells,
in the presence of the ERK inhibitor SHC 772984. Scale bars, 200 mm. (D) Quantification of sprouts area for the
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Furthermore, we performed a microarray study to analyze the gene expression profiles of
DICERWT and DICERKD spheroids. GSEA comparison showed levels of expression of ‘cell cycle’- and
‘metabolism of nucleotides’-related genes in DICERKDspheroids that were higher than those in
DICERWT spheroids stimulated with VEGF-A (Figure 6E), but no higher than those in control sphe-
roids (Figure 6—figure supplement 1C). These findings indicate that the activity of miRNAs can
restrain the expression of genes that promote cell proliferation following VEGF-A stimulation, in
agreement with the network analysis (Figure 3) and the results shown in Figure 2. This observation
was further validated by measuring proliferation rate in SPHC and SPHV (Figure 6F). DICERKD sphe-
roids displayed a VEGF-A-dependent increase of cell proliferation compared to DICERWT spheroids,
confirming that the removal of miRNAs allows activation of the proliferative pathway downstream of
VEGF-A. Interestingly, when the proliferation assay was performed on ECs cultured in 2D, DICERKD
cells showed a reduced proliferative response to VEGF compared to DICERWT cells, suggesting
that different miRNA activities are involved in the 2D or 3D environments (Figure 6—figure supple-
ment 1D).
Biological validation of the miRNA hub network regulating sprouting
angiogenesis
As previously shown, network analysis indicates that only few miRNAs are predicted to target a large
number of protein-coding genes (Figure 4—source data 1), in agreement with the scale-free
hypothesis that describes real networks. These hub miRNAs therefore should be pivotal to the net-
work architecture and to the post-transcriptional regulatory activity that sustains the sprouting pro-
cess. To validate the accuracy of the network analysis, and the relevance of the predicted miRNA-
mediated post-transcriptional control of the genetic program sustaining SA, we subjected two
miRNAs to further investigations. To validate the network, we selected miR-424–5p and miR-29a-3p,
which are well-known miRNAs involved in angiogenesis regulation, and showed a high number of
interactions with coding genes. miR-424–5 p was upregulated and targeted 98 genes,
which were mainly related to intracellular signaling, including the MAPK pathway (Figure 5A) and
cell cycle control (Figure 7A and Figure 4—source data 1). miR-29a-3p was downregulated and
controlled the post-transcriptional regulation of 25 genes, mostly related to extracellular matrix
remodeling (Figure 7B and Figure 4—source data 1). These miRNA–target interactions are also
reported in the publicly available databases miRTarBase (Chou et al., 2018), TarBase
(Karagkouni et al., 2018) and starBase (Li et al., 2014), which store miRNA–mRNA interactions sup-
ported by experimental evidence. In particular, for miR-424–5 p, 97 out of 98 interactions were pres-
ent in these databases (24 of them in all three databases, and 73 in one or two); for miR-29a-3p, 23
out of 25 interactions were present in the databases (7 of them in all three databases, 16 in
one or two) (Figure 7—source data 1). RNAseq expression data for miR-424–5p and miR-29a-3p in
SPHC and SPHV were confirmed by real-time PCR analysis (Figure 7—figure supplement 1A,
B). The expression of these two miRNAs can also be altered when the Notch pathway is manipu-
lated. In fact, inhibition of the Notch pathway with DAPT, which increases sprouting (Figure 1—fig-
ure supplement 2B), increased the expression of miR-424–5p and reduced the expression of miR-
29a-3p; the opposite effect was obtained when spheroids were treated with exogenous DLL4
(Figure 7C,D).
To assess the role of miR-424–5p and miR-29a-3p in the sprouting process, we altered their
expression in ECs by using miRNA mimics or inhibitors (Figure 7—figure supplement 1D,E), and
Figure 6 continued
cells shown in panel (C). Data are represented as mean ± SEM from n = 3 experiments. (E) GSEA study performed
against the canonical pathways gene sets collection showed positive enrichment in the ’cell cycle’ and
’metabolism of nucleotides’ gene sets, in the comparison between DICERKD and DICERWT stimulated spheroids
(SPHV). FDR was accepted when q value < 0.05. (F) Cell proliferation assessed by cytofluorimetric analysis of EdU
incorporation into the DNA in spheroids generated from DICERWT cells or DICERKD cells that were either not
stimulated (SPHC) or stimulated (SPHV) with VEGF-A. Representative plots of n = 3 experiments. Data represent
mean percentages of proliferating cells ± SEM from n = 3 experiments. **, p<0.01; *, p<0.05.
The online version of this article includes the following figure supplement(s) for figure 6:
Figure supplement 1. DICER knock-down.
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Figure 7. Hub miRNAs are essential to the sprouting process. Graphical representation of miR-424–5p (A) and miR-29a-3p (B) sub-networks,
characterized by different patterns of functional classes target genes. (C) Real-time PCR analysis of miR-424–5p expression in SPHV treated with DAPT
or with exogenous DLL4. Data are represented as mean ± SEM from n = 3 experiments. (D) Real-time PCR analysis of miR-29a-3p expression in SPHV
treated with DAPT or with exogenous DLL4. Data are represented as mean ± SEM for n = 3 experiments. (E) Sprouting assay performed with ECs
transfected with miR-424–5p or miR-29a-3p mimics and inhibitors. Scale bars, 200 mm. (F) Quantification of sprout area for the cells shown in panel (E).
Data are represented as mean ± SEM from n = 4 experiments. (G) Real-time PCR assays in EC transfected with miR-424–5p mimic detecting the
expression of miR-424–5p targets predicted from the network analysis. Data are represented as mean ± SEM from n = 3 experiments. (H) Real-time PCR
assays in EC transfected with miR-29a-3p mimic detecting the expression of miR-29a-3p targets predicted from the network analysis. Data are
represented as mean ± SEM from n = 3 experiments. ****, p<0.0001; ***, p<0.001; **, p<0.01; *, p<0.05.
The online version of this article includes the following source data and figure supplement(s) for figure 7:
Source data 1. Hub miRNA interactions supported by experimental evidence.
Figure supplement 1. miR-424–5p, miR-29a-3p and miR-16–5 p gain of function and loss of function.
Figure supplement 2. Tip competition assay.
Figure supplement 3. Assessment of VEGF-A-induced cell proliferation and migration upon modulation of miR-424–5p or miR-29a-3p.
Figure 7 continued on next page
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performed the sprouting assay (Figure 7E). Quantification of sprout areas (Figure 7F) indicated that
both upregulation by miRNA mimics and downregulation by miRNA inhibitors of miR-424–5p and
miR-29a-3p impaired the ability of ECs to sprout, suggesting that the equilibrium of the network
architecture requires that the expression of these two hub miRNAs is maintained at controlled levels.
In a tip competition assay, spheroids were generated by mixing an equal number of ECs expressing
the fluorescent protein DsRed with ECs transfected with miR-424–5p or miR-29a-3p mimics or inhibi-
tors. Fluorescent or non-fluorescent cells occupying the tip position of the sprouts were counted.
Figure 7—figure supplement 2 shows that cells with altered expression of miR-424–5p or miR-29a-
3p were impaired in reaching the tip cell position. To ascertain the robustness of the gain-of-func-
tion/loss-of-function approach, we also altered the expression of miR-16–5 p, which belongs to the
same family as miRNA-424–5p, with which it putatively shares the same subset of target genes. How-
ever, our network analysis, which integrates target predictions with expression data, predicted a dif-
ferent subset of target genes for miR-424–5p and miR-16–5 p in the spheroid model (Figure 4—
source data 1), and miR-16–5 p appeared to be a more peripheral miRNA that had only 16 pre-
dicted target genes. Indeed, miR-16–5 p modulation did not affect sprouting (Figure 7—figure sup-
plement 1F,G). miR-424–5p and miR-29a-3p expression was significantly reduced in DICERKD
spheroids compared to DICERWT spheroids (Figure 7—figure supplement 1H), suggesting that
impaired expression of these two miRNAs could account, at least in part, for the sprouting defects
observed in spheroids after DICER knock-down and in agreement with their role in network hierar-
chy. Furthermore, modulation of miR-424–5p, which is involved in the MAPK sub-network shown in
Figure 5A, resulted in the alteration of P-ERK activity according to the bioinformatics prediction,
whereas modulation of miR-29a-3p, which is not involved in this network, was not effective (Fig-
ure 7—figure supplement 1I).
The effect of modulation of miR-424–5p and miR-29a-3p on cell proliferation was also tested in
the spheroid model, the limitation of this assay being that the inhibition of cell proliferation cannot
be evaluated as it is already close to zero. Indeed, none of the treatments could significantly increase
cell proliferation (Figure 7—figure supplement 3A). In a 2D VEGF-dependent cell proliferation
assay, however, treatment with the miR-424–5p mimic was able to reduce cell proliferation by 50%
(Figure 7—figure supplement 3B). When tested in a 2D VEGF-dependent cell migration experi-
ment, the miR-424–5p mimic had a positive effect on cell migration, whereas the miR-29a-3p mimic
had a negative effect, the latter in agreement with its predicted role as a negative regulator of cell
migration. miRNA inhibitors, however, did not show any significant effect (Figure 7—figure supple-
ment 3C).
To further validate miR-424–5p and miR-29a-3p activity in the different biological pathways iden-
tified by the network analysis, we used real-time PCR to analyze the expression of 10 predicted tar-
get genes for miR-424–5p and 10 for miR-29a-3p. The targets investigated included genes involved
in cell proliferation control (MAP2K1, CCND2), as well as genes involved in cell migration and extra-
cellular remodeling (ITGA2, NID1), whose alteration could account for the phenotype observed.
Indeed, we were able to verify a reduction in the expression of target genes when the corresponding
miRNA mimic was overexpressed (Figure 7H,I). The effect of the miRNA inhibitors on the selected
targets was, however, less pronounced, and we were able to observe upregulation for only three tar-
get genes for each condition (Figure 7—figure supplement 4A,B). Therefore, we analyzed the
expression of other miR-424–5p and miR-29a-3p targets that are present in their respective miRNA
subnetworks and that were not previously analyzed. For most of these target genes, we observed a
significant upregulation upon inhibition of miRNAs (Figure 7—figure supplement 4C,D).
Modulation of miRNA hubs alters network architecture
The data showed above indicate, for some of the experiments performed, a non-symmetrical effect
of miRNA upmodulation and downmodulation. This might be explained by the existence of a
broader effect on the network architecture that would involve indirect miRNA–miRNA interactions.
To gain more insights into the impact that modulation of a hub miRNA can have on the global
Figure 7 continued
Figure supplement 4. Gene expression analysis of miR-424–5p and miR-29a-3p target genes upon miRNA inhibition.
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network architecture, we analyzed the expression of a large panel of miRNAs (of which 127 are rep-
resented in the SA network) by TaqMan array microRNA cards when miR-424–5p or miR-29a-3p
were either upregulated or downregulated. The results indicate that 76 miRNAs showed altered
expression (|DDCt| > 2) upon up- or downmodulation of miR-424–5p or miR-29a-3p in at least two
conditions (Figure 8A). In particular, when the analysis was restricted to the subset of miRNAs that
share common target genes with miR-424–5p or miR-29a-3p in the SA network, 27 of these miRNAs
showed altered expression (Figure 8B). Interestingly, several miRNAs showed increased expression
under the effect of miR-424–5p or miR-29a-3p inhibitors. Altogether, these data indicate that that
miR-424–5p and miR-29a-3p modulations induce a deep rewiring of the global miRNA network in
addition to the modulation of their target coding genes, which can also account for the differences
observed when comparing the effects of miRNA mimics and miRNA inhibitors.
Upregulation of genes that are targeted by miRNAs during sprouting
angiogenesis correlates with tumor angiogenesis
To extend the results derived from the SA model in a human setting, and to identify possible impli-
cations of our findings in tumor biology, we evaluated the expression of the global upregulated and
downregulated gene modules extracted from the network analysis, as well as the expression of sin-
gle miRNA targets, in a collection of colorectal cancers (CRC). This type of tumor was chosen
because angiogenesis plays an important role in its progression (Battaglin et al., 2018), and some
of the patients benefit from anti-angiogenic therapy with the VEGF blocker bevacizumab. 450 CRC
samples were first ranked by their endothelial gene signature or endothelial score, a parameter that
takes into account the expression of 35 EC-specific genes, not expressed by CRC or other stromal
components, and that correlates with ongoing angiogenesis (Isella et al., 2015). When GSEA was
used to correlate the different miRNA-target gene subsets obtained from the network analysis (Fig-
ure 4—source data 1) with CRC samples, we observed a significant positive enrichment for the miR-
29a-3p-targets subset (Figure 9A), meaning that expression of miR-29a-3p targets is higher in CRCs
that have a high endothelial score. Furthermore, average expression in CRC samples of the genes
that were present in the network analysis and that are upregulated in SPHV (upregulated module,
Figure 9—source data 1) also showed a significant positive correlation with endothelial score
(Figure 9B). Likewise, GSEA analysis in which the endothelial score was used as phenotype classifier
revealed a significant enrichment of the upregulated module (Figure 9C) and allowed the identifica-
tion of a core gene set of 58 genes that are coherently regulated in vitro and in vivo (Figure 9—
source data 1). This gene subset was further challenged in a dataset from CRC patients treated with
the VEGF inhibitor bevacizumab (Pentheroudakis et al., 2014). Indeed, the core subset of the upre-
gulated gene module was significantly enriched in bevacizumab-responding patients (Figure 9D),
thus confirming the involvement of the genes within this module during pathological angiogenic
remodeling.
Discussion
The spheroid model as a tool to study tip cell selection
In this study, we generated protein-coding gene and miRNAs RNAseq data from a VEGF-A depen-
dent, well-established three-dimensional model of SA (Korff and Augustin, 1998; Nowak-
Sliwinska et al., 2018). We showed that initial response to VEGF-A in ECs consists of a profound
remodeling of the transcriptome, which allows differentiation toward the tip phenotype. This
includes the activation of genes that regulate extracellular matrix remodeling, which is essential to
the migratory process, and the repression of genes that promote cell proliferation and nucleotide
de novo synthesis (Figure 1B and Figure 2). The observation that these two fundamental VEGF-A
downstream pathways might not be synchronous in tip cells is in agreement with earlier studies on
pathophysiological angiogenesis, in which it was demonstrated that the onset of vascular sprouting
depends on the migration of existing ECs and does not require EC proliferation (Ausprunk and
Folkman, 1977; Sholley et al., 1984). The spheroid model described here cannot, however, recapit-
ulate all of the molecular events that lead to the formation of a more complex vascular
bed. Furthermore, it cannot allow the analysis of tip-stalk cell dynamics because of the inability to
differentiate stalk cells properly. This can be attributed to the intrinsic short life of the model
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Figure 8. Modulation of miRNA hubs alters network architecture. (A) Heatmap showing the result of a differential
gene expression analysis of a panel of miRNAs upon up- or downmodulation of miR-424–5p or miR-29a-3p. Only
miRNAs with |DDCt| > 2 are represented. Color bar indicates –DDCt values. (B) Heatmap showing only those
differentially expressed miRNAs that have predicted target genes in common with miR-424–5p or miR-29a-3p.
Color bar indicates –DDCt values.
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compared to the mouse retina model and to the absence of other co-regulatory events, such as the
generation of a VEGF gradient by neurons (Okabe et al., 2014). Nonetheless, the specificity of this
model in the generation of tip cells allowed the analysis, at a molecular level, of the post-transcrip-
tional regulation that sustains tip cells selection.
Functions of miRNA in the context of regulatory networks
Here, information about the expression of miRNAs was used to generate a global post-transcrip-
tional regulatory network based on co-expression between miRNAs and their predicted protein-cod-
ing target genes. Using this unbiased approach, we were able to emphasize a role of miRNAs
in repressing genes that regulate cell proliferation and other signaling pathways downstream of
VEGF. Such pathways include the MAPKs signaling cascade, which is mainly involved in transducing
the VEGF-A mitogenic signal. Meanwhile, miRNAs also promoted the expression of genes
that are involved in extracellular matrix remodeling.
Several studies have highlighted the importance of both transcriptional and post-transcriptional
interactions in the shaping of global regulatory networks. The connections involving both transcrip-
tion factors and miRNAs can be described in terms of small regulatory patterns (Hornstein and
Shomron, 2006; Tsang et al., 2007). Some circuits topologies, in their incoherent form, can be asso-
ciated with positive correlation patterns between the expression of miRNAs and their predicted tar-
get genes, and are generally thought to have a buffering function on transcriptional noise. On the
other hand, the coherent form of miRNA-target circuits is thought to mediate a post-transcriptional
reinforcement of transcriptional regulation and is associated with negative correlation schemes of
gene expression (Cora’ et al., 2017). Our experimental setup intrinsically highlights and selects such
negative correlations (Figure 3B). In this context, miRNA activity is meant to reinforce the transcrip-
tional program and to facilitate phenotypic transitions by precisely shaping a genetic program
that is triggered by external cues (Ebert and Sharp, 2012). In principle, however, we cannot
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Figure 9. Upregulation of genes that are targeted by miRNAs during SA correlates with tumor angiogenesis. (A)
GSEA plot showing significant positive association for miR-29a-3p target genes in CRC samples stratified by their
endothelial score. (B) Scatter plot showing correlation, in CRC samples, between the expression of genes that
constitute the upregulated gene module from the network analysis and endothelial score. (C) GSEA plot showing
significant positive association for the up-gene module with CRC samples stratified by their endothelial score. (D)
GSEA plot showing significant positive association for the upregulated genes core, extracted from panel (B), with
a cohort of bevacizumab-responding CRC patients (bev-resp), compared to not-responding patients (bev-not
resp). FDR was accepted when q value < 0.05.
The online version of this article includes the following source data for figure 9:
Source data 1. Genes constituting the upregulated gene module and the enrichment core in CRC.
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preclude the presence, among the miRNA–gene network presented, of a later layer of indirect inter-
actions between miRNAs and their targets or between the miRNAs themselves that is able to fine-
tune the behavior of the network elements.
Regulation of MAP kinase activity by miRNAs
To demonstrate carefully the robustness of the post-transcriptional regulatory network described
here at a system level, we performed a series of experimental validation by envisaging two different
approaches: 1) removal of mature miRNAs by DICER knock-down to evaluate the global effects of
miRNA-mediated post-transcriptional activity on SA, and 2) validation of predicted targets for two
miRNAs identified as hubs from the network analysis. For the first validation approach, we focused
on a MAPK-specific subnetwork, due to its role in cell proliferation control, that pinpointed a coordi-
nated miRNA inhibitory activity on the ERK module, represented by the RAF1, MAP2K1 and MAPK1
genes (Figure 5A). Removal of mature miRNAs by means of DICER knock-down reverted the down-
regulation of these genes that was observed after VEGF-A stimulus (Figure 5B and Figure 6A),
increased P-ERK activity (Figure 6B), and restored a proliferative response (Figure 6F). Although the
process that is triggered by a mitogenic stimulus depends on subsequent substrate phosphorylation
throughout the MAPK cascade, it has been shown that the final outcome can also be influenced by
miRNA-mediated post-transcriptional regulation of MAPK genes themselves. In particular, and
in accordance with the interactions presented in this work, RAF1 targeting by miR-497 inhibits breast
cancer cell growth (Li et al., 2011), whereas downregulation of miR-424 leads to aberrant cell prolif-
eration through MEK1 (MAP2K1) upregulation in senile hemangioma (Nakashima et al., 2010).
Here, we also identified novel miRNA–MAPK interactions, such as miR-424–5p targeting MAP2K1
and MAP3K3, or miR-19b-3p and miR-320b/c targeting MAPK1, although more specific experimen-
tal validations are required to demonstrate the function of these interactions.
Our data also indicate that the effect of miRNA activity in ECs is highly context-dependent. In
fact, previous studies attributed the angiogenesis defects induced by DICER inhibition to a reduction
of VEGF-induced proliferation (Sua´rez et al., 2007; Sua´rez et al., 2008). However, the mechanistic
demonstration of this hypothesis was limited to in vitro experiments that used 2D-cultured ECs only.
Although we confirmed the reported effects of DICER inhibition in 2D cultures, we
also demonstrated that the activation of ECs that enables tip cell selection and migration (the first
step in SA [Carmeliet and Jain, 2011]) benefits from a miRNA-mediated inhibition of cell prolifera-
tion. Therefore, in the more complex in vivo scenario, in which different ratios of migratory (tip) and
proliferating (stalk) ECs exist simultaneously, miRNAs could have different effects depending on the
EC phenotype considered. Nevertheless, owing to its broad effect on the expression of miRNAs,
DICER inhibition could also have affected regulatory pathways other than ERK, and thus could have
contributed to the observed phenotype.
Role of two hub miRNAs in the post-transcriptional regulatory network
For the second validation approach, we focused on two hub miRNAs: miR-424–5p and miR-29a-3p,
which belong to the network component containing up- and downregulated miRNAs, respectively.
Their expression could be further modulated when the Notch pathway is either repressed or acti-
vated (Figure 7C,D), supporting the concept that their regulation promotes tip cell specification.
Earlier studies in two-dimensional EC cultures reported that miR-424–5p upregulation reduced
VEGF-induced proliferation (Chamorro-Jorganes et al., 2011), or indirectly modulated HIF-a
expression thus promoting angiogenesis (Ghosh et al., 2010), whereas miR-29a inhibition impaired
cell-cycle progression (Yang et al., 2013). However, it is also known that a widespread feature of
miRNA activity toward a specific target is context-dependency, which also highlights the importance
of target validation under physiological conditions (Erhard et al., 2014). In our three-dimensional
model, integration of expression data with target prediction allowed the identification of context-
specific targets. In fact, miR-424–5p showed preferential targeting activity towards genes
that are associated with cell-cycle progression and intercellular signaling, whereas miR-29a-3p activ-
ity was more specific to genes involved in extracellular matrix remodeling (Figure 7A,B). A similar
targeting pattern, for both miRNAs, has been described in previous evidence-based computational
studies in different cellular models (Tsang et al., 2010). Our independent analyses in ECs support
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the concept that a single miRNA can act on different targets belonging to the same pathway to rein-
force its biological effect.
Finally, our unbiased approach disclosed an unpredicted hierarchical role of miR-424–5p and miR-
29a-3p in a complex process such as SA. In fact, perturbation of miR-424–5p and miR-29a-3p expres-
sion levels propagated throughout the network, causing alterations in the expression levels of a
large number of other miRNAs, including miRNAs that share coding targets with miR-424–5p or mir-
29a-3p. Considering that each gene in the network is targeted by several different miRNAs, such
broad network rearrangement could explain why inhibition of a single miRNA did not result in a sig-
nificant increase in the expression of all its targets in a predictable way, and why inhibition of miR-
424–5p alone was not as effective as removal of miRNAs by DICER knock-down in rescuing cell pro-
liferation upon VEGF-A stimulus.
Signature of the activity of miRNAs in tumor angiogenesis
To prove the strength of our experimental design and extend our findings to clinical data, we investi-
gated the angiogenic post-transcriptional activity in human tumors. Indeed, in a collection of 450
CRC, we successfully challenged the correlation between gene modules that constitute a signature
of the activity of miRNAs and ongoing angiogenesis in the stromal compartment. A significant corre-
lation was, however, not detected for the downregulated gene modules, which mostly included cell-
proliferation-associated genes. This can be explained by the fact that, in whole tumor transcriptomic
data, the signal from the highly proliferating epithelial cancer cells overcome the signal coming from
the less represented ECs. In addition, a signature composed of 58 sprouting-associated genes,
which also included miR-29a-3p targets, was able to identify patients who benefitted from anti-
angiogenic treatment with the VEGF-A blocking agent bevacizumab. On one side, this strengthens
the evidence of the involvement of post-transcriptional regulation in tumor angiogenesis, and on the
other side, it paves the way for future development of predictive markers for VEGF-A blocking
agents. This analysis could also be extended to other cancer types, such as ovarian, cervical, non-
small cell lung cancer or glioblastoma, in which angiogenesis is recognized to support tumor growth
and in which bevacizumab is an approved therapeutic option. In summary, network analysis of whole
transcriptomic data obtained from an in vitro SA model identified miRNA-mediated regulatory mod-
ules that fine-tune the response of ECs to VEGF-A and that could be exploited to identify new drug-
gable biomarkers in angiogenesis-related diseases.
Materials and methods
Primary cell cultures
Human umbilical vein endothelial cells (HUVECs) were isolated from the cords of newborns by colla-
genase digestion of the interior of the umbilical vein, as previously described (Nowak-
Sliwinska et al., 2018). To reduce the experimental variability that results from the different genetic
backgrounds of individuals, each HUVEC batch was composed of cells derived from three to five dif-
ferent cords. HUVECs were cultured in M199 medium supplemented with 20% fetal bovine serum
(FBS), 0.05 mg/ml porcine heparin, 2% penicillin-streptomycin solution (all from Sigma-Aldrich, St.
Louis, MO, USA) and 0.2% brain extract. HUVECs were used for experiments until the third passage.
Collection of umbilical cords for the isolation of HUVECs is governed by an agreement between Uni-
versita` degli Studi di Torino and the Azienda Ospedaliera Ordine Mauriziano di Torino, protocol
number 1431 02/09/2014. Informed consent was obtained from all subjects involved.
Spheroid capillary sprouting assay
EC spheroids were generated as described previously (Nowak-Sliwinska et al., 2018) with minor
modifications. HUVECs within the third passage were trypsinized and cultured in hanging drops (800
cells/drop) in M199 containing 10% FBS and 0.4% (w/v) methylcellulose (Sigma-Aldrich). After 10 hr
or overnight incubation, spheroids were collected and embedded in a solution containing 15% FBS,
0.5% (w/v) methylcellulose, 1 mg/ml rat tail collagen I solution, 30 Mm HEPES and M199 from 10X
concentrate (all from Sigma-Aldrich). 0.1M NaOH was added to adjust the pH to 7.4 to induce colla-
gen polymerization. After 30 min incubation at 37˚C, polymerized gel was overlaid with M199
medium. Sprouting was induced by addition of 20 ng/ml recombinant human VEGF-A (R and D
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Systems, Minneapolis, MN, USA) to the collagen solution and to the overlaying medium. After 18 hr
incubation at 37˚C in a 5% CO2 incubator, spheroids were imaged, or collected for further analysis.
When indicated, inactivation of cell proliferation was performed by treating the cells with mitomycin
C (Sigma-Aldrich) at 10 mg/ml for 2 hr in M199, 24 hr prior spheroids generation. When spheroids
assay was performed in the presence of drugs, the drugs were added at the moment of collagen I
embedding. The fluorescent ECs used in the tip competition assay were generated by transduction
with lentiviral particles carrying the plasmid pLVX-DsRed-Express2-N1 (Takara, Mountain View, CA,
USA) followed by puromycin selection for 48 hr. For experiment of Notch pathway modulation,
spheroids were incubated with either DAPT (Sigma-Aldrich) 2 mM or human recombinant DLL4 (R
and D Systems) 1 mg/ml.
Imaging
Spheroids in 3D collagen matrix were fixed with 4% PFA for 30 min at room temperature and
imaged under bright field using an AF6000LX-TIRF workstation (Leica, Wetzlar, Germany). Measure-
ment of the total sprout area of individual spheroids was performed using the Image J software
package. For each experimental condition, the sprout area of at least 20 spheroids was measured
and averaged to achieve 5% significance and 80% power.
RNA isolation
To isolate ECs after the sprouting assay, the collagen matrix was digested by incubation with 0.25%
Collagenase A (Sigma-Aldrich) in M199 medium at 37˚C for 10 min. Total RNA was isolated from
HUVECs by using TRIzol (ThermoFisher Scientific, Waltham, MA, USA) reagent and an miRNeasy
Mini Kit (Qiagen, Hilden, Germany). Residual DNA was removed by treatment with Rnase-Free
Dnase Set (Qiagen). The quality and concentration of RNAs were assessed with a NanoDrop ND-
1000 spectrophotometer (ThermoFisher Scientific). The quality of the RNA samples that were subse-
quently processed for RNA-sequencing and microarray analysis was further assessed using a Qubit
RNA HS Assay Kit and an Agilent RNA 6000 Nano Kit in an Agilent Bioanalyzer (Agilent, Santa Clara,
CA, USA).
RNA-sequencing analysis
Total RNA from spheroids exposed to VEGF-A for 18 hr (SPHV) and control spheroids
(SPHC) that were not exposed to VEGF-A were subjected to high throughput sequencing for poly-A
+ RNAs by an external next generation sequencing (NGS) facility (Fasteris, Geneva, Switzerland).
Three biological replicates from each biological condition were analyzed. RNA sequencing was per-
formed on a HiSeq 2000 sequencer (Illumina, San Diego, CA, USA), obtaining a mean of 100 million
paired-end reads of 100 bps per sample. Reads to counts conversion and differential expression
analysis were performed using the software implementation described by Beccuti et al. (2018). In
brief, fastq files were mapped with STAR-2.5 to the reference genome (hg19 assembly) and gene
counts were generated using RSEM-1.3.0 and ENSEMBL annotation. Differential expression analysis
was performed using DESeq2 version 1.14.1 (Love et al., 2014) to detect modulated genes (| log2FC
|>0.5 and FDR < 0.05). Data were deposited in the GEO database, with accession number
GSE115817.
For miRNAs, the same external NGS facility (Fasteris, Geneva, Switzerland) was used to perform
small-RNA sequencing profiling on the same matched samples as those used for mRNA sequencing.
Sequencing was performed on a HiSeq 2000 sequencer (Illumina), obtaining a mean of 8 million 50-
bps single-end reads per sample. From the raw data, adaptors were first trimmed by the FASTX-
Toolkit. Then, inserts were mapped by the BWA tool (Li and Durbin, 2010) on mature miRNA
sequences from miRBase v22 (Kozomara and Griffiths-Jones, 2014), thus producing an expression
level for all annotated miRNAs. Data were deposited in the GEO database, with accession number
GSE115954.
Microarray analysis
450 ng total RNA was employed to synthetize biotinylated cRNA probes using an Illumina TotalPrep
RNA Amplification Kit (ThermoFisher Scientific), according to the manufacturer’s instructions. After
quantification in an Agilent Bioanalyzer, 750 ng cRNAs were hybridized to an Illumina HumanHT-12
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v4.0 Expression Bead Chip for 18 hr at 58˚C. Biotinylated probes were then labeled with streptavi-
din-Cy3. Fluorescent signal was acquired by an Illumina BeadArray Reader, and data were extracted
using the GenomeStudio software V2011.01. Probe intensities across the chip were normalized by
applying the cubic spline normalization algorithm. For subsequent analysis, only probes with a detec-
tion p-value <0.05 were selected. For each gene, we retained the associated probe with the largest
mean expression value across all samples. For each probe, the log2 signal was converted to the log2
ratio against the global average expression of that probe in all samples. Each experimental point
was assessed with two biological replicates. Data were deposited in the GEO database, with acces-
sion numbersGSE116039 and GSE129275.
Gene set enrichment analysis (GSEA)
GSEA was run on the dataset of protein-coding genes in SPHV versus SPHC against the canonical
pathway genesets collection (c2.cp.v5.2, Broad Institute) by using 1000 genesets permutations. Only
genesets with FDR < 0.05 were considered. Meta-analysis on colorectal cancer was performed on
RNAseq data provided by The Cancer Genome Atlas (TCGA) (Cancer Genome Atlas Network,
2012), and on microarray data from the GEO Series GSE53127. GSEA was performed by evaluating
the enrichment of upregulated modules and miRNA targets for genes that had high correlation with
endothelial scores. Only genesets with FDR < 0.05 were considered.
Generation of the post-transcriptional network
Pair-wise correlation analysis was performed on the gene expression profiles of protein-coding
genes and miRNAs from the RNA-sequencing data of SPHC and SPHV samples by using Pearson
correlation as co-expression measure. Association between functional biological pathways and miR-
NAs was performed using the GSEA algorithm. Briefly, miRNA expression data were used as
the phenotype to calculate the Pearson correlation coefficient between each pair of miRNA and pro-
tein-coding genes and to find association with biological processes. Genesets with FDR < 0.05 that
positively or negatively correlated with miRNAs expression were extracted and used to generate a
matrix that was subsequently clusterized using GenePattern (Broad Institute). Genes constituting the
core enrichment were extracted from significant genesets and subjected to functional annotation
using the online David functional annotation platform. To find associations between miRNA and their
protein-coding target genes, we extracted data from TargetScan database V7.1, selecting evolution-
arily conserved interactions with a weighted context++ score percentile >50. For non-conserved
interactions, we considered a weighted context++ score percentile >90. Graphical representation
of networks was performed using Cytoscape software, version 3.3.0 (Shannon et al., 2003). Power-
law fitting and the corresponding statistical analysis were performed in MATLAB, according to
Clauset et al. (2009).
Real-time PCR
To analyze mRNAs expression, 1 mg of DNAse-treated RNA was reverse-transcribed using a High
Capacity cDNA Reverse Transcription kit and random primers (ThermoFisher Scientific). cDNA ampli-
fication was performed using gene-specific TaqMan assays and TaqMan PCR Universal MasterMix
(ThermoFisher Scientific) in a CFX96 thermocycler (Bio-Rad, Hercules, CA, USA). Each assay was run
in triplicate. To analyze miRNA expression, 350 ng of DNAse-treated RNA was reverse-transcribed
using a High Capacity cDNA Reverse Transcription kit in the presence of a miRNA-specific primer
(ThermoFisher Scientific). Real-time PCR was performed using miRNA-specific TaqMan MicroRNA
Assays and TaqMan Universal PCR Master Mix (ThermoFisher Scientific) in a CFX96 (Bio-Rad) Real-
Time PCR. Each assay was run in triplicate. Expression of TBP or RNU44 was used as
the endogenous control for mRNA or miRNA relative quantifications, respectively. Relative quantifi-
cation of gene expression levels between samples (Rq) was performed using the comparative Ct
(threshold cycle number) method (Livak and Schmittgen, 2001). A complete list of the Real-time
PCR assays used is provided in Supplementary file 2.
miRNA expression profiling under miRNA hubs modulation was performed using TaqMan
Advanced miRNA Human A Card (ThermoFisher Scientific). 10 ng of total RNA from each sample
were retrotranscribed using a TaqMan Advanced miRNA cDNA Synthesis Kit (ThermoFisher Scien-
tific). Each sample was run in biological duplicate. Expression data were first normalized following
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manufacturer’s instructions; subsequently, the DDCt method was used to evaluate the relative
expression level (fold change) in each condition versus the corresponding control. DDCt values were
loaded in the R environment software for statistical analysis and the heatmap function was used to
perform hierarchical clustering analysis and to represent data in a heatmap.
Transient transfections
Sub-confluent ECs were transfected with the mirVana miRNA mimic, to overexpress miRNAs, or
with mirVana miRNA inhibitor (ThermoFisher Scientific), to inhibit miRNAs activity, at a final concen-
tration of 90 nmol/L by using RNAiMAX lipofectamine in Optimem medium (ThermoFisher Scien-
tific), according to the manufacturer protocol. Effective overexpression or inhibition was verified by
real-time PCR, as described. Subsequent assays were performed 24 hr post-transfection.
shRNA-mediated gene knock-down
DICER1 knock-down was performed by transducing ECs with shRNAs carried by lentiviral particles.
Self-inactivating, replication-incompetent lentiviral particles were generated by cotransfection of
expression plasmid (TRC1 pLKO.1-puro Non-Target shRNA as negative control or TRC1 pLKO.1-
puro carrying DICER1-targeting shRNAs, Sigma-Aldrich), envelope plasmid (pVSV-G) and packaging
plasmid (pCMV-Dr8.91) into HEK-293t cells using the calcium phosphate method, as previously
described (Follenzi et al., 2000). ECs were transduced with lentiviral particles at a multiplicity of
infection (MOI) = 1 in the presence of 8 mg/ml polybrene. Medium was replaced after 24 hr, and cells
stably expressing the shRNA were selected by growth in puromycin (1 mg/ml) for 24 hr. Effective
DICER knock-down of two different shRNAs was evaluated by real-time PCR. The shRNA with
the highest silencing efficacy was chosen (sh#3) and used for subsequent experiments. Spheroid
assays were performed 48 hr post-transduction.
Western blot analysis
Total proteins were obtained by cell lysis in an extraction buffer containing 0.125 M Tris-HCl (pH
6.8), 4% SDS, 20% glycerol, and quantified by BCA assay (ThermoFisher Scientific). Equal amounts of
protein extract per sample were separated on an SDS-PAGE and subsequently blotted onto a PVDF
membrane. Membranes were incubated with specific primary antibodies and appropriate HRP-conju-
gated secondary antibodies. Immunoreactive proteins were visualized using an enhanced chemilumi-
nescence (ECL) system and acquired using a ChemiDoc Touch Gel Imaging System (Biorad). Images
were analyzed with Image Lab software 5.2.1 (Biorad). Antibodies used were anti-VEGFR2, anti-P38,
anti-phospho-P38, anti-ERK1/2, anti-phospho-ERK1/2 (Cell Signaling Technology, Danvers, MA,
USA), and anti-GAPDH (Abcam, Cambridge, UK).
ERK activity assessment
Total ERK and phospho-ERK proteins were measured using the Meso Scale Discovery (MSD) technol-
ogy. MAP Kinase (Total Protein) Whole Cell Lysate Kit and MAP Kinase Whole Cell Lysate Kit MULTI-
SPOT plates were used (Meso Scale Diagnostics, Rockville, MA, USA) according to the MSD manu-
facturer’s information. 7 mg of each sample were used for the detection. The amount of phosphopro-
tein was calculated according to the MSD directions using the following formula: % phosphoprotein
= ((2 x phospho-signal) / (phospho-signal + total signal)) x 100.
Whole-mount immunofluorescent staining
Collagen gels containing spheroids were fixed with 4% paraformaldehyde for 30’ min, followed by 3
hr incubation in blocking buffer (PBS 0.5% Triton + 0.1% tween 20% and 10% donkey serum). Anti-
DLL4 antibody (Abcam) or anti-CXCR4 antibody (Abcam) were diluted 1:1000 in blocking buffer and
incubated overnight at 4˚C. After extensive washing in blocking buffer, collagen gels were incubated
with AF555-conjugated secondary antibody (ThermoFisher Scientific) in the same buffer for 1 hr. Cell
nuclei were counterstained with DAPI.
Notch signaling activity
The plasmid pWPT-12XCSL-DsRedExpressDR was generated by subcloning the Notch fluorescent
reporter 12xCSL-DsRedExpressDR (Hansson et al., 2006) into the lentiviral vector pWPT.
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Generation of lentiviral particles and transduction of ECs were performed as described above.
Spheroid assays were performed 48 hr post-transduction.
Proliferation assay
A proliferation assay was performed using Click-It EdU Flow Cytometry Cell Proliferation Assay
(ThermoFisher Scientific). For 2D proliferation assays, 2.5  103 ECs were plated in six well plates
and starved in serum-free M199 supplemented with 0.1% BSA for 10 hr. Cell proliferation was
induced by the addition of 20 ng/ml VEGF-A to the culture medium, and maintained for additional
18 hr. 10 mM of 5-ethynyl-20-deoxyuridine (EdU) was added 2 hr prior to cell harvesting. For cell pro-
liferation measurement in spheroids, 10 mM EdU was added 2 hr prior to spheroids collection. EdU
detection was performed according to the manufacturer’s protocol and samples were analyzed in a
CyAn ADP flow cytometer with Summit five software (Beckman Coulter, Brea, CA, USA).
Migration assay
Real-time directional cell migration was measured with an xCELLigence RTCA DP instrument in a
CIM plate (ACEA Biosciences, San Diego, CA, USA). The bottom of the upper chamber was coated
with 1% gelatin for 5 min at room temperature. The lower chamber was filled with M199 medium,
10% FBS, and VEGF 20 ng/ml as chemoattractant. 3  105 HUVECs were seeded in the upper cham-
ber in 100 ml M199 medium. ECs migration was continuously monitored by measuring the Cell Index
every 30 min for 24 hr in a CO2 incubator at 37˚C. Data were analyzed with the xCELLigence RTCA
software (ACEA Biosciences). The slope of the curve obtained by Cell Index measurements, which
represents the speed of cell migration, was calculated the slope.
Enzymatic activity measurements
Purine synthesis
The activity of glutamine amidophosphoribosyltransferase (PPAT) was measured as described previ-
ously (Capello et al., 2016). The [14C]-L-glutamate generated from the reaction was separated from
[14C]-L-glutamine by ion exchange chromatography in a 2 ml column. The radioactivity of the eluate
containing [14C]-L-glutamate was counted by liquid scintillation and expressed as nmol glutamate
(Glu)/h/mg cell proteins. The activity of aminoimidazole-4-carboxamide ribonucleotide formyltrans-
ferase/inosine monophosphate cyclohydrolase (ATIC) was measured as reported previously
(Boccalatte et al., 2009). Results were expressed as nmol NADP+/min/mg cell proteins.
Pyrimidine synthesis
The activity of carbamoyl phosphate synthetase II (CAD) was measured as described previously
(Capello et al., 2016). Results were expressed as pmol carbamoyl aspartate (CA)/min/mg cell
proteins.
ERK and p38 pharmacological inhibition
6  105 cells were plated in six well plates and pretreated with the ERK inhibitor SHC772984 (Cay-
man Chemical, Ann Arbor, MI, USA) or the p38 inhibitor SB 202190 (Sigma-Aldrich) for 18 hr, using
the following concentrations: 30, 100 or 300 nM for ERK inhibitor, and 10, 100 or 300 mM for p38
inhibitor. Cells were starved for 3 hr in serum-free M199 and then stimulated with 20 ng/ml VEGF-A
for 10 min. Starving and stimulation were performed in the presence of the drugs. Cells were then
processed for protein extraction and western blot analysis.
Statistical analyses
All statistical analyses were performed using the GraphPad Prism six software, the R statistical pack-
age, or MATLAB. For all the datasets included in t-tests, Shapiro-Wilk normality test was applied to
assess normal distribution. Pooled data are expressed as the mean ± SEM. n represents the number
of biological replicates, each performed with different HUVEC batches. Significance was determined
by using unpaired Student’s t-test (two tailed); p<0.05 was considered significant. Specific details for
each experiment can be found in the corresponding figure legend. Elsewhere, for hypergeometric
tests, p<0.05 was considered significant; for the Kolmogorov-Smirnov test, P > 0.1 was considered
significant.
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